Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cytochrome P450-dependent arachidonate metabolites, renal function and blood pressure regulation.

× No keyword cloud information.

7 in total

1. Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth.

Authors: Anna Alexanian; Victoriya A Rufanova; Bradley Miller; Averia Flasch; Richard J Roman; Andrey Sorokin
Journal: Anticancer Res Date: 2009-10 Impact factor: 2.480

2. Salt modulates vascular response through adenosine A(2A) receptor in eNOS-null mice: role of CYP450 epoxygenase and soluble epoxide hydrolase.

Authors: Mohammed A Nayeem; Darryl C Zeldin; Matthew A Boegehold; John R Falck
Journal: Mol Cell Biochem Date: 2010-12-14 Impact factor: 3.396

Review 3. Role of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertension.

Authors: Mairéad A Carroll
Journal: Prostaglandins Other Lipid Mediat Date: 2011-12-22 Impact factor: 3.072

Review 4. Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors: Kenneth I Strauss
Journal: Brain Behav Immun Date: 2007-11-08 Impact factor: 7.217

Review 5. Epoxy Fatty Acids Are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation.

Authors: Cindy McReynolds; Christophe Morisseau; Karen Wagner; Bruce Hammock
Journal: Adv Exp Med Biol Date: 2020 Impact factor: 2.622

6. Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.

Authors: Matthew Birnie; Ryan Morrison; Ramatoulie Camara; Kenneth I Strauss
Journal: BMC Genomics Date: 2013-05-04 Impact factor: 3.969

7. Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential.

Authors: Anna Alexanian; Andrey Sorokin
Journal: Onco Targets Ther Date: 2013-03-26 Impact factor: 4.147

7 in total